ALB and Hypoalbuminemia: Although linezolid pharmacokinetics could theoretically be influenced by low albumin levels—potentially increasing the free drug fraction, drug clearance, and Vd—no studies have clearly demonstrated a clinically significant impact [21], which seems unlikely unless severe hypoalbuminemia (<2 g/L) occurs.